ESTHER PEREZ: Open Payments
NPI 1528217528 · SALINAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 15 payments from 11 companies in 2025. Trend: 2023 $731 · 2024 $290 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 2 | $49 |
| RGH Enterprises LLC | 2 | $47 |
| Novo Nordisk Inc | 2 | $45 |
| Abbott Laboratories | 2 | $39 |
| Sequel Med Tech, LLC | 1 | $32 |
| Mannkind Corporation | 1 | $30 |
| Soleno Therapeutics, Inc. | 1 | $28 |
| Insulet Corporation | 1 | $23 |
| Tandem Diabetes Care, Inc. | 1 | $22 |
| Currax Pharmaceuticals LLC | 1 | $17 |
Products named: GVOKE HYPOPEN, FREESTYLE LIBRE 3, TWIIST, AFREZZA, VYKAT XR, Rybelsus, Omnipod, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across CA — which companies pay providers there.
